| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-81 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-81 |
| filingDate |
2015-11-19^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82503cb4da0a387a5a98341dbe01f2a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_949901c4564bd359e960d2b450c32bbf |
| publicationDate |
2017-07-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9701654-B2 |
| titleOfInvention |
Process for preparation of dronedarone by removal of hydroxyl group |
| abstract |
The invention relates to a novel process for preparation of dronedarone of formula (I) and pharmaceutically acceptable salts thereof the hydroxyl group is removed, and the obtained product is isolated and, if desired, converted into a pharmaceutically acceptable salt thereof. |
| priorityDate |
2012-02-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |